The gut microbiota consists of over 1000 different microbial species whose genetic material, known as the microbiome, is 100 times greater than that of human cells. It is now known that these genes serve a number of essential functions in the gastrointestinal tract and throughout the body. (4,5).
A key function of gut microbiota is to digest dietary fibre (which is their main source of energy) and convert it into metabolites, known as short chain fatty acids (SCFAs). There are three main SCFAs; butyrate, propionate and acetate. The main role of acetate is to help the growth of healthy bacteria and provide a substrate for the production more SCFAs. Butyrate and propionate are responsible for many of the essential functions performed by the gut microbiota both at the level of the gastrointestinal tract and in organs throughout the body. These functions include maintaining the integrity of the gut wall, modulating immune function, assisting with detoxification, supporting mitochondrial and metabolic functions and influencing energy homeostasis, appetite and brain function.
Other metabolites produced by the gut microbiota include vitamins, polyphenols and neurotransmitters, all of which play an important role in the body. (6,7,8,9)
The Gut Microbiota and Gut Wall Integrity
Butyrate provides approximately seventy percent of the energy used by enterocytes, the cells that line the gastrointestinal tract (10). This energy is used for cell renewal and function, and therefore for keeping the gut wall healthy. Butyrate can also activate certain genes that allow these cells to serve their intended function (11). For example, the goblet cell, a type of enterocyte, produces mucin, which is a component of mucus, a protective coating along the gut wall. Mucus helps prevent the passage of antigens (foreign substances) from the gut lumen into the circulation. Butyrate provides energy for goblet cells and it also activates a gene responsible for the production of a protein involved in mucin synthesis (12). In other enterocytes, butyrate activates genes that are responsible for the production of tight junction molecules (12). These molecules are found between enterocytes and prevent the passage of antigens into the circulation. In this way, SCFAs are able to help maintain the health and integrity of the gut wall.
An important fact to note is that the mucus layer of the gut wall contains carbohydrates. These carbohydrates can be digested by the gut microbiota if dietary fibre is inadequate. This leads to a breakdown of the mucus layer, exposing the enterocytes to antigens in the gut lumen. Dietary fibre is therefore essential for healthy diversity of gut microbiota (with fibre being food for good bacteria) and for maintaining the mucus layer and gut wall integrity.
Short - Chain Fatty Acids and Immune Function
Another essential role of SCFAs is to stimulate a healthy immune response. The gut wall contains approximately eight percent of our immune cells. These cells are located between enterocytes, within lymph nodes or within areas called peyer’s patches – all of which are present along the entire gastrointestinal tract. (13,14).
SCFAs attach to receptors on these immune cells and activate them in order to produce a well-controlled immune response when they come in contact with any antigens or pathogens. When the gut microbiota has a healthy diversity, this response is mild and self-limiting and is known as a state of “immune tolerance”. Immune tolerance is beneficial to the host as it quickly and effectively deals with foreign substances without causing damage to the gut or other tissues. (13,14).
Other Functions of the Gut Microbiota
The gut microbiota also influence other functions in the body by
Modifying genetic activity in various cells throughout the body (11,14).
Improving the absorption of essential nutrients.(15)
Supporting the function of mitochondria, the organelle that provides energy to cells. (16,17)
Producing vitamins that are used by gut microbiota and host cells (eg b-group vitamins and vitamin K) (18,19)
Increasing the bioavailability of dietary antioxidants (20).
Assisting detoxification by secreting enzymes that neutralize ingested toxins.(21-23)
Up-regulating the production of detoxification enzymes in enterocytes and liver cells.(21-23)
Stimulating enterocytes to produce molecules and neurotransmitters that are responsible for regulating appetite and energy balance. (24-28)
Sending signals to the brain via the Vagus nerve and neuroendocrine system. This communication is known as the gut-brain connection. (28,29)
More information on all of the above functions is provided in the BiomeMD™ manual.
When things go wrong...
Studies show that a number of factors can alter the composition of the gut microbiota – a state that is commonly termed dysbiosis. Consuming a diet high in processed foods, chronic stress, insomnia and certain medications such as antibiotics, antacids or anti-inflammatory drugs are some of the factors that can lead to dysbiosis (30-34). Dysbiosis is associated with a reduction in beneficial (SCFA-producing) bacteria and an increase in pathogenic bacteria in the gut. These changes in the composition of the gut microbiota have repeatedly been linked to obesity in humans and mice (35,36).
Chronic states of dysbiosis can lead to damage of the mucus layer and tight junctions, therefore resulting in gaps between enterocytes. These gaps allow the passage of antigens from the gut lumen into the circulation, a process commonly termed leaky gut. When antigens cross the gut wall they have the capacity to over-activate immune cells and produce a pro-inflammatory response which results in further damage to the gut wall. Prolonged over-stimulation of the immune system can lead to systemic inflammation, which has been linked to number of metabolic derangements such as obesity and insulin resistance (37-43).
Inflammation and weight management
Systemic inflammation is now recognised as a key driver of obesity and weight gain. It is also associated with a range of metabolic and hormonal abnormalities that make it more difficult to lose fat and maintain a lower weight. Studies show that systemic inflammation is also associated with inflammation in adipose tissue and brain matter (44).
Inflammation within adipose tissue leads to insulin resistance and fat gain. It also changes the function and hormonal output of fats cells. Normally, as fat cells enlarge, they secrete a hormone called leptin which sends signals of fullness to the brain and reduces food intake. When adipose tissue becomes inflamed, leptin signals are altered and eventually stop being detected by the brain. This is why some people report that they never feel satisfied or that they have no “off-switch” when it comes to food, despite carrying excess weight (45-46).
Inflammation in the brain, known as neuroinflammation, can affect a number of areas in the brain that are involved with weight management (47-53).
The hypothalamus is an area of the brain involved in appetite control, energy balance and the stress response. Hypothalamic inflammation impairs our ability to detect signals of fullness, resulting in increased hunger and food intake, and a reduction in energy expenditure (54-58).
The corticolimbic system includes areas of the brain that are involved in cognitive function, learning, emotional control and the stress response (to name a few). When these areas are altered, our ability to manage stress, employ cognitive restraint and overcome urges is impaired (59-61).
In addition, neuroinflammation alters the production of neurotransmitters responsible for mood, sleep and appetite. It also impairs neurogenesis, the process by which our brain remodels to form new neural pathways (61). This is important when it comes to developing and maintaining new behaviours and lifestyle patterns related to weight management. If neurogenesis is impaired it is difficult, if not impossible, to develop new behaviours and sustain them long-term.
When it comes to weight management, it is essential to restore a healthy microbial diversity and prevent systemic inflammation. For most people, the general principles delivered in the BiomeMD™ protocol will provide these results. For those who suffer from autoimmune symptoms, food intolerances, glucose sensitivity or various symptoms for which no medical cause has been identified, modifications can be made by the practitioner in order to address these individual needs.
© BioAesthetics 2016-2020. All rights reserved.
Various aspects of the BiomeMD™ protocol and nutrient formulations are protected under patent pending application.
1. F. Bäckhed, J.K. Manchester, C.F. Semenkovich, J.I. Gordon Mechanisms underlying the resistance to diet-induced obesity in germ-free mice Proc. Natl. Acad. Sci. U. S. A., 104 (2007), pp. 979-984
2. C.K. Fleissner, N. Huebel, M.M.A. El-Bary, G.Loh, S. Klaus, M. Blaut Absence of intestinal microbiota does not protect mice from diet-induced obesity Br. J. Nutr., 104 (2010), pp. 919-929
3. F. Bäckhed, H. Ding, T. Wang, L.V. Hooper, G.Y.Koh, A. Nagy, et al. The gut microbiota as an environmental factor that regulates fat storage Proc. Natl. Acad. Sci. U. S. A., 101 (2004), pp. 15718-15723
4. Hugon P., Dufour J.-C., Colson P., Fournier P.-E., Sallah K., Raoult D. (2015) A comprehensive repertoire of prokaryotic species identified in human beings. Lancet Infect. Dis. 15, 1211–1219 doi:10.1016/S1473-3099(15)00293-5
5. McGuckin M.A., Lindén S.K., Sutton P. and Florin T.H. (2011) Mucin dynamics and enteric pathogens. Nat Rev Microbiol 9, 265–278 doi:10.1038/nrmicro2538
6. Gill S.R., Pop M., DeBoy R.T., Eckburg P.B., Turnbaugh P.J., Samuel B.S. et al. (2006) Metagenomic analysis of the human distal gut microbiome. Science 312, 1355–1359 doi:10.1126/science.1124234
7. A.W. Walker, S.H. Duncan, E.C.M. Leitch, M.W. Child, H.J. Flint PH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon Appl. Environ. Microbiol., 2005
8. G. Macfarlane, J. Cummings, C. Allison J. Gen. Protein degradation by human intestinal bacteria Microbiol., 1985
9. H.M. Hamer, V. De Preter, K. Windey, K. Verbeke Am. J. Functional analysis of colonic bacterial metabolism: relevant to health? Physiol. Gastrointest. Liver Physiol., 2012
10. Corrêa-Oliveira R., Fachi J.L., Vieira A., Sato F.T. and Vinolo M.A.R. (2016) Regulation of immune cell function by short-chain fatty acids. Clin Transl Immunol 5, e73 doi:10.1038/cti.2016.17
11 Bhat MI, Kapila R. Dietary metabolites derived from gut microbiota: critical modulators of epigenetic changes in mammals. Nutr Rev. 2017 May 1;75(5):374-389. doi: 10.1093/nutrit/nux001.
12. Morrison D.J. and Preston T. (2016) Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 7, 189–200 doi:10.1080/19490976.2015.1134082
13. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, et al. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 2003;278:11312–9.
14. Delcenserie V, Martel D, Lamoureux M, Amiot J, Boutin Y, Roy D. Immunomodulatory effects of probiotics in the intestinal tract. Curr Issues Mol Biol. 2008;10:37–54.
15. Magnúsdóttir S, Ravcheev D, de Crécy-Lagard V, Thiele I (2015) Systematic genome assessment of B-vitamin biosynthesis suggests co-operation among gut microbes. Front Genet 6:148
16. Clark A and Mach N (2017) The Crosstalk between the Gut Microbiota and Mitochondria during Exercise. Front. Physiol. 8:319. doi: 10.3389/fphys.2017.00319
17. Donohoe DR, Garge N, Zhang X, et al. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab. 2011;13(5):517-26.
18. Gustafsson BE, Daft FS, McDaniel EG et al (1962) Effects of vitamin K-active compounds and intestinal micro-organisms in vitamin K-deficient germfree rats. J Nutr 78:461–468
19. Said HM (2013) Recent advances in transport of water-soluble vitamins in organs of the digestive system: a focus on the colon and the pancreas. Am J Physiol Gastrointest Liver Physiol 305:G601–G610
20. Rechner AR, Smith MA, Kuhnle G et al (2004) Colonic metabolism of dietary polyphenols: influence of structure on microbial fermentation products. Free Radic Biol Med 36:212–225
21. Nayak RR, Turnbaugh PJ. Mirror, mirror on the wall: which microbiomes will help heal them all? BMC Medicine 2016;14:72.
22. Li-Wan-Po A. 2013. The human genome: its modifications and interactions with those of the microbiome, and the practice of genomic medicine. Discov Med 15:283–290.
23. Beatrice Louise Pool-Zobel, Veeriah Selvaraju, Julia Sauer, Tanja Kautenburger, Jeannette Kiefer, Konrad Klaus Richter, Malle Soom, Stefan Wölfl; Butyrate may enhance toxicological defence in primary, adenoma and tumor human colon cells by favourably modulating expression of glutathione S -transferases genes, an approach in nutrigenomics , Carcinogenesis, Volume 26, Issue 6, 1 June 2005, Pages 1064–1076,
24. Holzer P, Reichmann F, Farzi A. Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis. Neuropeptides. 2012;46:261–274."
25. Dockray GJ. Gastrointestinal hormones and the dialogue between gut and brain [published online March 17, 2014]. J Physiol. doi: 10.1113/jphysiol.2014.270850"
26. Kimura I, et al. The SCFA receptor GPR43 and energy metabolism. Front. Endocrinol. 2014;5:85.
27. Inoue D, et al. Regulation of energy homeostasis by GPR41. Front. Endocrinol. 2014;5:81.
28. Cryan JF, Dinan TG: Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci2012;13:701–712
29. Borovikova L.V. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000;405:458–462.
30. Biagi E., Candela M., Turroni S., Garagnani P., Franceschi C., Brigidi P. (2013) Ageing and gut microbes: perspectives for health maintenance and longevity. Pharmacol. Res. 69, 11–20 doi:10.1016/j.phrs.2012.10.005
31. Rodriguez J.M., et al. (2015) The composition of the gut microbiota throughout life, with an emphasis on early life. Microb. Ecol. Health Dis. 26, 26050.
32. Biedermann L., Zeitz J., Mwinyi J., Sutter-Minder E., Rehman A., Ott S.J. et al. (2013) Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans. PLoS One8, e59260 doi:10.1371/journal.pone.0059260
33. Tyakht A.V., Kostryukova E.S., Popenko A.S., Belenikin M.S., Pavlenko A.V., Larin A.K. et al. (2013) Human gut microbiota community structures in urban and rural populations in russia. Nature Commun 4, 2469 doi:10.1038/ncomms3469
34. Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 2004;101:15718e23.
35. Lau E, Carvalho D, Pina-Vaz C, Barbosa J-A, Freitas P. Beyond gut microbiota: understanding obesity and type 2 diabetes. Horm Athens Greece 2015;14:358–69
36. Boulangé CL, Neves AL, Chilloux J, Nicholson JK, Dumas M-E. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med 2016;8:42
37. Dao MC, Everard A, Aron-Wisnewsky J, Sokolovska N, Prifti E, Verger EO, et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut 2015.
38. Davis JE, Gabler NK, Walker-Daniels J, Spurlock ME. Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat. Obesity (Silver Spring) 2008; 16(6): 1248–1255."
39. Bioceuticals Technical Education Brochure, Zonulin, Leaky Gut and Autoimmune Disease MM.1625 070416_1
40. Pillon NJ, Bilan PJ, Fink LN, Klip A. Cross-talk between skeletal muscle and immune cells: muscle-derived mediators and metabolic implications. Am J Physiol Endocrinol Metab 2013; 304(5): E453–E465.
41. Langlet C, Tamoutounour S, Henri S, et al. CD64 expression distinguishes monocyte-derived and conventional dendritic cells and reveals their distinct role during intramuscular immunization. J Immunol 2012; 188(4): 1751–1760."
42. Chmelar J, Chung KJ, Chavakis T. The role of innate immune cells in obese adipose tissue inflammation and development of insulin resistance. Thromb Haemost 2013; 109(3): 399–406."
43. Ghanim H, Abuaysheh S, Sia CL, Korzeniewski K, Chaudhuri A, Fernandez- Real JM, et al. Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care. 2009;32:2281–7. doi:10.2337/dc09-0979.
44. Bleau, Christian & Karelis, Antony & St-Pierre, David & Lamontagne, Lucie. (2014). Crosstalk between intestinal microbiota, adipose tissue and skeletal muscle as an early event in systemic low grade inflammation and the development of obesity and diabetes. Diabetes/Metabolism Research and Reviews. 31. 10.1002/dmrr.2617.
45. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW, Jr.: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112:1796-1808.
46. N. Ouchi, J.L. Parker, J.J. Lugus, K. Walsh, Adipokines in inflammation and metabolic disease, Nat. Rev. Immunol. 11 (2011) 85–97.
47. Morris G, Anderson G, Dean O, Berk M, Galecki P, Martin-Subero M, et al. The glutathione system: a new drug target in neuroimmune disorders. Mol Neurobiol. 2014;50:1059–84. doi: 10.1007/s12035-014-8705-x
48. Fischer MT, Sharma R, Lim JL, Haider L, Frischer JM, Drexhage J, et al. NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury. Brain. 2012;135:886–99. doi: 10.1093/brain/aws012
49. Gilgun-Sherki Y, Melamed E, Offen D. The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J Neurol. 2004;251:261–8. doi: 10.1007/s00415-004-0348-9.
50. Prolo C, Alvarez MN, Radi R. Peroxynitrite, a potent macrophage-derived oxidizing cytotoxin to combat invading pathogens. Biofactors. 2014;40:215–25. doi: 10.1002/biof.1150.
51. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med. 2010;49:1603–16. doi: 10.1016/j.freeradbiomed.2010.09.006.
52. Vaziri ND. Causal link between oxidative stress, inflammation, and hypertension. Iran J Kidney Dis. 2008;2:1–10.
53. Alvarez MN, Peluffo G, Piacenza L, Radi R. Intraphagosomal peroxynitrite as a macrophage-derived cytotoxin against internalized Trypanosoma cruzi: consequences for oxidative killing and role of microbial peroxiredoxins in infectivity. J Biol Chem. 2011;286:6627–40. doi: 10.1074/jbc.M110.167247
54. "JP Thaler, CX Yi, EA Schur, SJ Guyenet, BH Hwang, MO Dietrich, et al. Obesity is associated with hypothalamic injury in rodents and humans J Clin Invest, 122 (2012), pp. 153-162"
55. Zhang X, Zhang G, Zhang H, Karin M, Bai H, Cai D (2008) Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell 135:61–73.
56. M. Milanski, G. Degasperi, A. Coope, et al., Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity, J. Neurosci. 29 (2009)
57. S. Carraro, Rodrigo & Souza, Gabriela & Solon, Carina & Razolli, Daniela & Chausse, Bruno & Barbizan, Roberta & Victório, Sheila & Velloso, Licio. (2017). Hypothalamic mitochondrial abnormalities occur downstream of inflammation in diet-induced obesity. Molecular and Cellular Endocrinology. 460. 10.1016/j.mce.2017.07.029.
58. CT De Souza, EP Araujo, S Bordin, R Ashimine, RL Zollner, AC Boschero, et al. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus Endocrinology, 146 (2005), pp. 4192-4199
59. T.L. Davidson, S.L. Hargrave, S.E. Swithers, et al., Inter-relationships among diet, obesity and hippocampal-dependent cognitive function, Neuroscience 253 (2013) 110–122.
60. C. Boitard, A. Cavaroc, J. Sauvant, et al., Impairment of hippocampal-dependent memory induced by juvenile high-fat diet intake is associated with enhanced hippocampal inflammation in rats, Brain Behav. Immun. 40 (2014) 9–17.
61. H.R. Park, M. Park, J. Choi, K.Y. Park, H.Y. Chung, J. Lee, A high-fat diet impairs
neurogenesis: involvement of lipid peroxidation and brain-derived neurotrophic factor, Neurosci. Lett. 482 (2010) 235–239.